Growth of Healthcare Industry in India

Growth of Healthcare Industry in India - Infographic

India's hospital market was valued at US$ 98.98 billion in 2023, projected to grow at a CAGR of 8.0% from 2024 to 2032, reaching an estimated value of US$ 193.59 billion by 2032.

Advantage India

Strong
Demand

* The demand for Indian healthcare professionals is expected to double nationally and globally by 2030.

* India has approximately 1.3 hospital beds per 1,000 population (or ~13 beds per 10,000), significantly lower than the global median of 29 beds, highlighting substantial opportunities for healthcare infrastructure expansion.

Attractive
Opportunities

* India’s public expenditure on healthcare is expected to be 1.9% of GDP in FY26, compared to 2.5% in FY25, as per the Economic Survey 2024-25.

* In Q3 2025, the pharma, hospital, and biotech sectors recorded 72 deals worth US$ 3.5 billion, marking a 166% increase in total deal value compared to the previous quarter, reflecting strong investment momentum and consolidation activity.

Rising
Manpower

* Availability of a large pool of well-trained medical professionals in the country.

* India's healthcare workforce has already exceeded 6 million as of CY24. However, this represents only the beginning, as the sector is anticipated to experience substantial growth, with over 6.3 million additional jobs expected by CY30.

Policy and
government support

* The Government aims to develop India as a global healthcare hub.

* The Union Budget 2026–27 allocated Rs. 1,06,530.42 crore (US$ 12.05 billion) to the Ministry of Health and Family Welfare, marking a ~10% increase over the Revised Estimates of FY 2025–26 (Rs. 96,853 crore).

* The government has allocated Rs. 9,500 crore (US$ 1.08 billion) for Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) in FY27.

Snapshot Showcase Infographics Reports

Last updated: Feb, 2026

Related News

3 Jun 26

Serum Institute of India to manufacture Oxford Ebola vaccine backed by US$ 8.6 million CEPI funding...

The Serum Institute of India (SII) will manufacture trial doses of Oxford University’s experimental Ebola vaccine, supported by CEPI funding, to accelerate protection against the Bundibugyo Ebola outbreak in Africa.

2 Jun 26

Wockhardt鈥檚 Zaynich Gains US FDA Approval, Opens Access to US$ 9 Billion Antibiotics Market...

The US FDA approval of Zaynich highlights India’s growing strength in pharmaceutical innovation and reinforces the country’s role in developing advanced treatments for global healthcare challenges.

1 Jun 26

Union Minister of Commerce and Industry Mr. Piyush Goyal Holds High-Level Business and Investment Engagements with Top Global Industry Leaders in New York...

Union Minister Mr. Piyush Goyal met top U.S. business leaders in New York to promote India’s investment opportunities, reform-driven growth and collaboration in key sectors including finance, healthcare, manufacturing and AI.

20 May 26

India-EFTA TEPA to Support US$ 100 billion Investments and 1 million Jobs: Prime Minister Mr. Narendra Modi...

India and Norway strengthened economic ties at the India-Norway Business and Research Summit in Oslo, focusing on green growth, maritime cooperation, renewable energy, advanced technologies and sustainable investments under the India-EFTA TEPA.

12 May 26

Novartis Expands India Role in Global Drug Development...

Novartis is expanding India’s role in global drug development through increased focus on research, clinical operations, AI-enabled innovation and advanced pharmaceutical capabilities.

Major Healthcare Centers in India

Delhi
Mumbai
Hyderabad
Kolkata
Chennai
Bengaluru
Ahmedabad

Industry Contacts

Posters

Healthcare Companies in India

With over 2.5 million operations performed and 20 million patients treated in the last 30 years, Aravind Eye Care System is the largest eye care provider in the world.